CLINICAL_TRIALS
trial_result
· 2014-02-07
Clinical Trial Update: STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia [Phase 2]
Summary
A Phase 2 trial evaluating imatinib (STI 571/Glivec) in adults with acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED